Graham Naismith

Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

Craig Mowat, Ian Arnott, Aiden Cahill et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 106 citations · Full text

Medicine, Pharmacotherapy, Surgery +14

A prospective single‐centre evaluation of the intra‐individual variability of faecal calprotectin in quiescent <scp>C</scp>rohn's disease

Graham Naismith, L Smith, Sarah Barry et al. · Alimentary Pharmacology & Therapeutics · 2013 · 71 citations · Full text

Medicine, Pathology, Gastroenterology +12

Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

Nikolas Plevris, Cher Shiong Chuah, Rhiannon Allen et al. · Journal of Crohn s and Colitis · 2019 · 51 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease

Graham Naismith, L Smith, Sarah Barry et al. · Journal of Crohn s and Colitis · 2014 · 48 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort

Nikolas Plevris, James Fulforth, Spyros I. Siakavellas et al. · Journal of Gastroenterology and Hepatology · 2020 · 40 citations

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +16